Nogo-A inhibitors are agents designed to block the activity of Nogo-A, thereby promoting axonal growth and neural repair. These inhibitors include monoclonal antibodies like anti-Nogo-A antibodies, receptor antagonists, and small molecule inhibitors. Clinical trials are underway to evaluate their efficacy in treating CNS injuries and neurodegenerative diseases.
